Atlas Trials

A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

Clinical trial NCT03449251 · UNKNOWN

Trial details

NCT number
NCT03449251
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiovascular DiseasesType 2 Diabetes Mellitus
Start date
2018-03-28
Primary completion
2025-09-01
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.